EcoDrugPlus

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSLCAG00010020311
Gene Symbol: LOC108891441
3 Cross references
317 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSLCAG00010018040
Gene Symbol: TGFBR1B
1 Cross references
204 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSLCAG00010014925
Gene Symbol: TRPA1B
1 Cross references
200 Possible Orthologues:

Transthyretin (Prealbumin, Amyloidosis Type I)

Ensembl ID : ENSLCAG00010018444
Gene Symbol: LOC108900674
4 Cross references
178 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSLCAG00010010510
Gene Symbol: TPH1A
4 Cross references
207 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSLCAG00010015994
Gene Symbol: LOC108887588
4 Cross references
204 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSLCAG00010011538
Gene Symbol: TUBA4A
4 Cross references
170 Possible Orthologues:

Tubulin Alpha Chain

Ensembl ID : ENSLCAG00010020120
Gene Symbol: LOC108880471
4 Cross references
156 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSLCAG00010024366
Gene Symbol: LOC108888647
3 Cross references
41 Possible Orthologues:

Tubulin Alpha-1b Chain

Ensembl ID : ENSLCAG00010016896
Gene Symbol: LOC108888647
3 Cross references
48 Possible Orthologues:

Tubulin Beta-2a Chain

Ensembl ID : ENSLCAG00010010387
Gene Symbol: LOC108883425
4 Cross references
305 Possible Orthologues:

Tubulin Beta-4b Chain

Ensembl ID : ENSLCAG00010022311
Gene Symbol: LOC108896145
3 Cross references
21 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).